Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. (Q46165919)
Jump to navigation
Jump to search
scientific article published on 12 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. |
scientific article published on 12 January 2009 |
Statements
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells (English)
Mercedes N López
Cristian Pereda
Leonel Muñoz
Raquel Aguilera
Fermín E González
Alejandro Escobar
Alexandra Ginesta
Diego Reyes
Rodrigo González
Ariadna Mendoza-Naranjo
Milton Larrondo
Alvaro Compán
Carlos Ferrada
Flavio Salazar-Onfray
12 January 2009